Jubilant Life Sciences gets US FDA nod
The drug is indicated for the acute treatment of migraine in adults and paediatric patients Jubilant Life Sciences has received…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Jubilant Life sciences
Jubilant Life Sciences gets US FDA nod for anti-migraine tablets
The company's drug is a generic version of AstraZeneca's Zomig-ZMT tablets, which is used for acute treatment of migraine…
Jubilant Life Sciences posts consolidated revenue at Rs 1,459 crore in Q1FY 2016
Income from operations of the pharma segment was at Rs 741 crore The Board of Jubilant Life Sciences has approved the financial…
Jubilant Life Sciences receives ANDA approval for Levofloxacin tabs
It is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin…
Jubilant Life Sciences increases price of Niacinamide
Jubilant Life Sciences announced a price increase of 10 per cent for Niacinamide, with immediate effect, for non-contract…
US FDA upgrades Jubilant’s Spokane facility to VAI status
It is indicative of the cGMP status at the facility since receiving the warning letter in 2013
Jubilant Life Sciences conferred with Golden Peacock National Quality Award
Recognised for consistent efforts in quality enhancement
Jubilant Life Sciences posts Q4 & FY 2015 results
Revenue was posted at Rs 763 crore and consolidated revenue was at Rs 5,826 crore
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Jubilant Life Sciences conferred with Golden Peacock National Quality Award
Recognised under the ‘Chemicals and Pharmaceutical category’ for consistent efforts in quality enhancement